Stock GLUE MONTE ROSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Monte Rosa Therapeutics, Inc.

Equities

GLUE

US61225M1027

Market Closed - Nasdaq
Other stock markets
 21:00:00 20/06/2024 BST 		5-day change 1st Jan Change
3.56 USD +0.56% Intraday chart for Monte Rosa Therapeutics, Inc. -11.22% -36.99%
06-14 Monte Rosa Therapeutics, Inc. Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis CI
05-30 Monte Rosa Therapeutics Names Three Insiders to Leadership Team MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MONTE ROSA THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+0.56%-11.22%-36.99%-53.16% - 216M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. GLUE Stock
  4. Charts Monte Rosa Therapeutics, Inc.
  5. Comparison Chart